S&P 500   3,376.04 (+0.08%)
DOW   27,943.75 (+0.17%)
QQQ   271.70 (-0.29%)
AAPL   455.41 (-1.01%)
MSFT   208.37 (-0.16%)
FB   259.83 (-0.56%)
GOOGL   1,507.48 (-0.60%)
AMZN   3,147.73 (-0.42%)
NVDA   460.29 (+0.56%)
CGC   17.18 (-0.81%)
BABA   252.56 (-0.46%)
TSLA   1,647.40 (+1.63%)
GE   6.68 (+1.21%)
MU   45.74 (-0.87%)
AMD   81.30 (-0.66%)
T   30.13 (+0.74%)
F   7.09 (+0.85%)
ACB   10.58 (+3.93%)
GILD   68.43 (+0.37%)
NFLX   482.61 (+0.27%)
DIS   130.70 (-0.20%)
BAC   26.52 (+0.65%)
BA   178.15 (+1.96%)
S&P 500   3,376.04 (+0.08%)
DOW   27,943.75 (+0.17%)
QQQ   271.70 (-0.29%)
AAPL   455.41 (-1.01%)
MSFT   208.37 (-0.16%)
FB   259.83 (-0.56%)
GOOGL   1,507.48 (-0.60%)
AMZN   3,147.73 (-0.42%)
NVDA   460.29 (+0.56%)
CGC   17.18 (-0.81%)
BABA   252.56 (-0.46%)
TSLA   1,647.40 (+1.63%)
GE   6.68 (+1.21%)
MU   45.74 (-0.87%)
AMD   81.30 (-0.66%)
T   30.13 (+0.74%)
F   7.09 (+0.85%)
ACB   10.58 (+3.93%)
GILD   68.43 (+0.37%)
NFLX   482.61 (+0.27%)
DIS   130.70 (-0.20%)
BAC   26.52 (+0.65%)
BA   178.15 (+1.96%)
S&P 500   3,376.04 (+0.08%)
DOW   27,943.75 (+0.17%)
QQQ   271.70 (-0.29%)
AAPL   455.41 (-1.01%)
MSFT   208.37 (-0.16%)
FB   259.83 (-0.56%)
GOOGL   1,507.48 (-0.60%)
AMZN   3,147.73 (-0.42%)
NVDA   460.29 (+0.56%)
CGC   17.18 (-0.81%)
BABA   252.56 (-0.46%)
TSLA   1,647.40 (+1.63%)
GE   6.68 (+1.21%)
MU   45.74 (-0.87%)
AMD   81.30 (-0.66%)
T   30.13 (+0.74%)
F   7.09 (+0.85%)
ACB   10.58 (+3.93%)
GILD   68.43 (+0.37%)
NFLX   482.61 (+0.27%)
DIS   130.70 (-0.20%)
BAC   26.52 (+0.65%)
BA   178.15 (+1.96%)
S&P 500   3,376.04 (+0.08%)
DOW   27,943.75 (+0.17%)
QQQ   271.70 (-0.29%)
AAPL   455.41 (-1.01%)
MSFT   208.37 (-0.16%)
FB   259.83 (-0.56%)
GOOGL   1,507.48 (-0.60%)
AMZN   3,147.73 (-0.42%)
NVDA   460.29 (+0.56%)
CGC   17.18 (-0.81%)
BABA   252.56 (-0.46%)
TSLA   1,647.40 (+1.63%)
GE   6.68 (+1.21%)
MU   45.74 (-0.87%)
AMD   81.30 (-0.66%)
T   30.13 (+0.74%)
F   7.09 (+0.85%)
ACB   10.58 (+3.93%)
GILD   68.43 (+0.37%)
NFLX   482.61 (+0.27%)
DIS   130.70 (-0.20%)
BAC   26.52 (+0.65%)
BA   178.15 (+1.96%)
Log in

NYSE:ELANElanco Animal Health Price Target & Analyst Ratings

$26.05
+1.61 (+6.59 %)
(As of 08/14/2020 12:18 PM ET)
Add
Compare
Today's Range
$24.41
Now: $26.05
$26.12
50-Day Range
$21.00
MA: $22.80
$25.42
52-Week Range
$15.17
Now: $26.05
$32.66
Volume162,988 shs
Average Volume5.39 million shs
Market Capitalization$10.39 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.91

Analyst Ratings

Elanco Animal Health (NYSE:ELAN) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
10 Wall Street analysts have issued ratings and price targets for Elanco Animal Health in the last 12 months. Their average twelve-month price target is $26.56, suggesting that the stock has a possible upside of 1.97%. The high price target for ELAN is $32.00 and the low price target for ELAN is $19.00. There are currently 1 sell rating, 4 hold ratings and 5 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldBuyBuyHold
Consensus Rating Score: 2.402.602.552.40
Ratings Breakdown: 1 Sell Rating(s)
4 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
6 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $26.56$29.20$29.20$33.00
Price Target Upside: 1.97% upside51.37% upside51.37% upside12.70% upside

Elanco Animal Health (NYSE:ELAN) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Elanco Animal Health (NYSE:ELAN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/12/2020Credit Suisse GroupInitiated CoverageNeutral$27.00Medium
8/4/2020Goldman Sachs GroupInitiated CoverageBuy$26.50High
7/27/2020Cleveland ResearchDowngradeNeutral ➝ Underperform$19.00High
7/20/2020Bank of AmericaBoost Price TargetBuy$26.00 ➝ $28.00Low
5/15/2020CitigroupLower Price TargetBuy$35.00 ➝ $27.00Medium
5/13/2020BarclaysReiterated RatingBuy$25.00Medium
4/2/2020Morgan StanleyDowngradeOverweight ➝ Equal WeightHigh
1/14/2020GabelliReiterated RatingBuyHigh
1/9/2020Raymond JamesInitiated CoverageMarket PerformHigh
11/20/2019UBS GroupLower Price TargetNeutral$30.00 ➝ $28.00Low
5/22/2019GuggenheimInitiated CoverageNeutral ➝ NeutralLow
5/10/2019BMO Capital MarketsBoost Price TargetMarket Perform$32.00 ➝ $35.00Low
2/11/2019William BlairInitiated CoverageMkt Perform ➝ Market Perform$29.71Medium
1/15/2019ArgusInitiated CoverageBuy$37.00Low
10/15/2018CowenInitiated CoverageOutperformLow
10/15/2018JPMorgan Chase & Co.Initiated CoverageOverweight ➝ Overweight$38.00Low
10/12/2018Craig HallumInitiated CoverageHoldLow
(Data available from 8/14/2018 forward)
This page was last updated on 8/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.